Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
about
Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancerBiological approaches to therapy of pancreatic cancer.MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro.Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice.
P2860
Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Antitumor effect of a new sele ...... xperimental pancreatic cancer.
@en
type
label
Antitumor effect of a new sele ...... xperimental pancreatic cancer.
@en
prefLabel
Antitumor effect of a new sele ...... xperimental pancreatic cancer.
@en
P2093
P2860
P356
P1476
Antitumor effect of a new sele ...... xperimental pancreatic cancer.
@en
P2093
P2860
P304
P356
10.1002/IJC.1199
P577
2001-05-01T00:00:00Z